Identification and Validation of a Threshold for Early Posttransplant Bronchoalveolar Fluid Hyaluronan that Distinguishes Lung Recipients at Risk for CLAD

By sjmartinez • October 25, 2024

Todd JL, Weber JM, Kelly FL, Nagler A, McArthur P, Eason L, Rim JG, Frankel CW, Belperio JA, Budev M, Martinu T, Patel K, Reynolds JM, Shah PD, Singer LG, Snyder LD, Tsuang W, Weigt SS, Neely ML, Palmer SM. Identification and Validation of a Threshold for Early Posttransplant Bronchoalveolar Fluid Hyaluronan that Distinguishes Lung Recipients at Risk for CLAD. J Heart Lung Transplant. 2024 Oct 22:S1053-2498(24)01900-4. doi: 10.1016/j.healun.2024.10.014. Epub ahead of print. PMID: 39448000.

Tags: bronchoalveolar lavage fluid, chronic lung allograft dysfunction, hyaluronan, Lung transplantation, Publications, Pulmonary, Critical Care & Sleep Medicine

Related Posts

Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene

Srinagesh HK, Gupta VK, Zhang A, Grunwald MR, Connor MP, Kota VK, Boccucci J, Ulrickson ML, Pradeep R, Hill LC, Tsai SB, O'Connor TE, Sandhu[...]

Reperfusion Strategies for Acute Pulmonary Embolism: Design and Rationale of RECONNECT-PE – a Living Systematic Review and Meta-analysis

Farmakis IT, Binder H, Chopard R, Christodoulou KC, Evrenoglou T, Fengler K, Giri J, Hobohm L, Jaber WA, Klok FA, Kocka V, Kroupa J, Kucher[...]

Neoadjuvant Stereotactic Body vs. Conventionally Fractionated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Propensity Score-Matched Analysis

Shimizu T, Zheng S, Maeda S, Link J, Deranteriassian A, Premji A, King J, Girgis M, Hines OJ, Wainberg Z, Raldow A, He J, Burns[...]